Kayne Richard D MD - CT New Haven, Cheshire 06410

Kayne Richard D MD entered the industry of Diabetes Doctors in 1989 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Diabetes Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Diabetes Doctors. The business provides service to the B2C market.

To acquire more information, please contact Richard Kayne by calling (203) 272-1619 during business hours. You can also write to the business’ Single Location at 577 South Main St, Cheshire, Connecticut CT 06410. You can also visit the company’s website at cheshirechiropractor.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Kayne Richard D MD
Representative: Richard Kayne
Place of Business: 577 South Main St, Cheshire, CT 06410
Contact Number: (203) 272-1619
Website: cheshirechiropractor.com
Type of Service: Diabetes Doctors
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1989
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Kayne Richard D MD is a company operating from New Haven, Connecticut providing professional Diabetes Doctors and relevant B2C variables. It was founded in 1989 and registered with the SIC code 8011 as Diabetes Doctors, and with the NAICS code 6211110 as Diabetes Doctors.

With a current employee count of 1 to 4, Kayne Richard D MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Richard Kayne at (203) 272-1619 for related queries, or to locate its Single Location using the coordinates 41.48782,-72.9051.

The Single Location can also be found at the street address 577 South Main St in Cheshire, Connecticut 06410 and can be engaged online through the company website at cheshirechiropractor.com, the company Twitter , and Facebook page .